You are currently viewing a new version of our website. To view the old version click .

Advances in Genetics and Precision Medicine in Human Diseases

Topic Information

Dear Colleagues,

Precision medicine is an emerging approach for disease treatment using genetics and genomics information. The majority of genetic variants are probably functionally neutral and can exert variant-specific effects on the regulation of gene expression. Such genetic variants are vital because they can be used as biomarkers that indicate the prognosis of potentially malignant and malignant lesions and may thus be involved in early intervention and diagnosis in patients at high risk. We are pleased to invite you to our Special Issue “Advances in Genetics and Precision Medicine in Human Diseases”. We look forward to receiving your contributions.

Prof. Dr. Shun-Fa Yang
Dr. Shih-Chi Su
Topic Editors

Keywords

  • genetics polymorphism
  • gene variant
  • genome-wide association studies
  • precision medicine
  • pharmacogenetics
  • mutation
  • epigenetics
  • cancer
  • biomarkers
  • single nucleotide polymorphism

Participating Journals

Cancers
Open Access
34,473 Articles
Launched in 2009
4.4Impact Factor
8.8CiteScore
20 DaysMedian Time to First Decision
Q2Highest JCR Category Ranking
Diagnostics
Open Access
17,188 Articles
Launched in 2011
3.3Impact Factor
5.9CiteScore
21 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking
Genes
Open Access
13,948 Articles
Launched in 2010
2.8Impact Factor
5.5CiteScore
15 DaysMedian Time to First Decision
Q2Highest JCR Category Ranking
Journal of Personalized Medicine
Open Access
7,546 Articles
Launched in 2011
-Impact Factor
6.0CiteScore
22 DaysMedian Time to First Decision
-Highest JCR Category Ranking
Pathogens
Open Access
8,918 Articles
Launched in 2012
3.3Impact Factor
6.8CiteScore
13 DaysMedian Time to First Decision
Q2Highest JCR Category Ranking
International Journal of Molecular Sciences
Open Access
106,411 Articles
Launched in 2000
4.9Impact Factor
9.0CiteScore
20 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking

Published Papers